Pozelimab Available Phase N/A Trials for CD59 Deficiency / CD55-deficient Protein-losing Enteropathy (PLE) / Paroxysmal Nocturnal Haemoglobinuria (PNH)

IndicationsStatusPurposePhase
AvailableNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT05232110Compassionate Use of Pozelimab